Among these episodes, nearly all instances (35 103 episodes ) of first coupon use occurred within the first 4 prescription fills. Results A total of 36 951 treatment episodes accounted for 238 474 drug claims and 35 352 unique patients (mean age, 48.1 years 17 676 women ). Main Outcomes and Measures The primary outcomes were (1) the frequency of coupon use, measured as the proportion of prescription fills accompanied by manufacturer coupon within the treatment episode, and (2) the timing of first coupon use relative to the first prescription fill within the treatment episode. This study focused on patients with 3 or more fills for a given drug and characterized the association of the outcomes of interest with patient, drug, and drug class characteristics. Patients with new treatment episodes using at least 1 manufacturer coupon over a 12-month period were identified. The data were analyzed from September to December 2022. Objectives To examine when and how frequently patients use manufacturer coupons during a treatment episode for a chronic condition, and to characterize factors associated with more frequent use.ĭesign, Setting, and Participants This is a retrospective cohort study of a 5% nationally representative sample of anonymized longitudinal retail pharmacy claims data from October 1, 2017, to September 30, 2019, obtained from IQVIA’s Formulary Impact Analyzer. Importance Although manufacturer-sponsored coupons are commonly used, little is known about how patients use them within a treatment episode. Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |